
The pharmacy chain SRx Pharma has been fined $30,000 for overbilling Indigenous Services Canada for drugs used to treat hepatitis C, after a Saskatoon pharmacist alerted the province's regulatory body to the practice.
from CBC | Health News https://ift.tt/nWbskYz
Aucun commentaire:
Enregistrer un commentaire